Skip to main content

ECG Diagnosis of Brugada Syndrome

 

Brugada Syndrome: ECG Diagnosis Made Simple


Brugada syndrome is an inherited primary electrical heart disease characterized by an increased risk of sudden cardiac death due to ventricular arrhythmias. Because patients often have a structurally normal heart, the electrocardiogram (ECG) plays a central role in its diagnosis.


Among the ECG-based tools, two measurements have gained particular importance:

✔️ The Ξ²-angle

✔️ The “Base of the Triangle” in the r′ wave


Both help differentiate true Brugada patterns from benign right bundle branch block (RBBB)-like variants.



---


1. Recognizing the Brugada ECG Pattern


The 3 Classical ECG Patterns


Brugada patterns are identified in the right precordial leads (V1–V3), ideally placed higher (V1–V2 in 2nd intercostal space) to increase diagnostic sensitivity.


πŸ”Έ Type 1 Brugada Pattern (Diagnostic)


Coved ST-segment elevation ≥ 2 mm


Followed by a negative T-wave


Characteristic “shark fin” or “coved” appearance



πŸ”Έ Type 2 & 3 Patterns (Suggestive but Not Diagnostic)


These show a saddleback appearance and may need drug challenge (ajmaline, flecainide) to unmask a diagnostic type 1 pattern.



---


2. Why the Ξ²-Angle and Triangle Base Matter


Not all r′ patterns in V1–V2 are Brugada. Some are benign, especially in athletes or due to normal variants.


The Ξ²-angle and triangle base improve diagnostic accuracy by assessing the shape of the r′ wave seen in Brugada syndrome.



---


3. How to Measure the Ξ²-Angle


The Ξ²-angle is the angle between:


1. The descending limb of the r′ wave



2. A horizontal line drawn at 5 mm below the r′ peak




πŸ”§ Step-by-Step Measurement


1. Identify the r′ peak in lead V1 or V2.



2. From the r′ peak, measure 5 mm downward (vertically).



3. Draw a horizontal line at that level.



4. Draw a line along the descending arm of the r′.



5. The angle where they meet is the Ξ²-angle.




πŸ“Œ Diagnostic Cutoff


Ξ²-angle ≥ 58° → Suggestive of Brugada syndrome


Smaller angles usually suggest benign r′ variants or incomplete RBBB.



Why it's useful


Brugada r′ waves tend to have a wide, slow descending slope, producing a large Ξ²-angle.



---


4. How to Measure the “Base of the Triangle”


Another method looks at the base width of the r′ wave when drawn as a triangle.


πŸ”§ Step-by-Step Measurement


1. Identify the r′ peak.



2. Draw vertical lines down from both the ascending and descending limbs of the r′ to the isoelectric line.



3. The distance between these two points is the base of the triangle.




πŸ“Œ Diagnostic Cutoff


Base ≥ 3.5 mm → Suggestive of Brugada


Narrow base → More likely a benign r′ variant



Physiological Meaning


A wide base indicates slower conduction in the right ventricular outflow tract — characteristic in Brugada syndrome.



---


5. Practical Pearls


Always record high intercostal V1–V2 to increase sensitivity.


Measure both the Ξ²-angle and triangle base if unsure.


Use multiple beats to avoid misinterpreting artifact.


Remember: only Type 1 pattern is diagnostic.


Consider sodium-channel blocker testing if suspicion remains high.




---


6. Summary Table


Feature Brugada r′ Benign r′ Variant


Ξ²-angle ≥58° <58°

Triangle base ≥3.5 mm <3.5 mm

ST segment Elevated (coved) Normal

T-wave Negative Usually upright




---


Conclusion


Brugada syndrome remains a challenging diagnosis, but using structured ECG criteria helps identify high-risk patients early. The Ξ²-angle and triangle base measurements add valuable precision, helping distinguish true Brugada patterns from benign variants.


Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.